RPG Life Sciences Ltd.
NSE: RPGLIFE | BSE: 532983
₹2,811.70
₹-81.10
(-2.80%)
As on 08-Oct-2026IST
Market cap
₹4,646 Cr
Revenue (TTM)
₹734 Cr
P/E Ratio
38.9
P/B Ratio
7.3
Div. Yield
0.9 %
Quality Score
9/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹119 Cr
-
ROE
20.3 %
-
ROCE
27 %
-
Industry P/E
57.24
-
EV/EBITDA
25.1
-
Debt to Equity
0
-
Book Value
₹384.5
-
EPS
₹70.5
-
Face value
8
-
Shares outstanding
16,539,015
10 Years Aggregate
CFO
₹560.52 Cr
EBITDA
₹857.56 Cr
Net Profit
₹610.55 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
RPG Life Sciences
| 21.1 | 5.2 | 15.2 | 22.9 | 30.3 | 32.4 | 19.2 |
|
BSE Healthcare
| 11.7 | -5.4 | -2.5 | 10.1 | 20.0 | 13.0 | 11.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
RPG Life Sciences
| 5.7 | 63.9 | 57.7 | 37.0 | 64.6 | 15.8 | 30.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
RPG Life Sciences
|
2,811.7 | 4,645.6 | 734.3 | 119.5 | 18.1 | 20.1 | 38.9 | 7.3 |
| 1,337.2 | 16,423.8 | 2,590.4 | 603.0 | 29.3 | 19.6 | 27.2 | 4.7 | |
| 518.6 | 9,826.3 | 885.7 | 234.9 | 27.8 | 18 | 41.8 | 4.4 | |
| 1,330.8 | 13,913.4 | 1,108.4 | 270.2 | 28.3 | 14.5 | 50.5 | 6.7 | |
| 1,851.5 | 35,120.2 | 9,683.5 | 1,019.0 | 15.7 | 21.3 | 34.7 | 6.7 | |
| 136.6 | 7,485.1 | 1,950.6 | 140.6 | 7.6 | 9.6 | 53.3 | 5.7 | |
| 21,015.0 | 26,961.3 | 2,371.8 | 497.8 | 28.0 | 28.5 | 54.2 | 13.3 | |
| 1,114.9 | 12,558.8 | 675.6 | 183.6 | 32.2 | 22.7 | 68.8 | 13.6 | |
| 288.9 | 8,154.8 | 8.8 | -352.4 | -4,228.0 | -80.8 | -- | 14.6 | |
| 1,093.8 | 7,031.9 | 869.2 | 109.9 | -- | 11.2 | 64 | 4.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About RPG Life Sciences
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs... in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust. Read more
-
Incorporated
2007
-
Chairman
Harsh Goenka
-
Managing Director
Ashok Nair
-
Group
RPG Enterprises
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for RPG Life Sciences
What is the current share price of RPG Life Sciences Ltd Today?
The share price of RPG Life Sciences Ltd is ₹2,811.70 (NSE) and ₹2,808.90 (BSE) as of 08-Oct-2026 IST. RPG Life Sciences Ltd has given a return of 30.26% in the last 3 years.
What is the current PB & PE ratio of RPG Life Sciences Ltd?
The P/E ratio of RPG Life Sciences Ltd is 38.89 times as on 08-Oct-2026, a 32 discount to its peers’ median range of 57.24 times.
The P/B ratio of RPG Life Sciences Ltd is 7.31 times as on 08-Oct-2026, a 55 premium to its peers’ median range of 4.71 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
26.57 |
5.05 |
2025 |
20.56 |
7.10 |
2024 |
28.87 |
6.75 |
2023 |
17.01 |
3.74 |
2022 |
17.98 |
3.62 |
What is the 52 Week High and Low of RPG Life Sciences Ltd?
The 52-week high and low of RPG Life Sciences Ltd are Rs 3,127.80 and Rs 1,733.00 as of 08-Oct-2026.
What is the market cap of RPG Life Sciences Ltd?
RPG Life Sciences Ltd has a market capitalisation of ₹ 4,646 Cr as on 08-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in RPG Life Sciences Ltd?
Before investing in RPG Life Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.